1-7 of 7
Sharyne M. Donfield
Close
Sort by
Journal Articles

Prompt Immune Tolerance Induction at Inhibitor Diagnosis Regardless of Titer May Increase Overall Success in Hemophilia A With Inhibitors: Experience of Two US Centers

Charles T Nakar, MD, Marilyn J. Manco-Johnson, MD, Alice Lail, MPH, Sharyne M. Donfield, PhD, Jennifer Maahs, MSN PNP, Young Chong, RN, Taylor A Blades, BS, Amy D. Shapiro, MD
Journal: Blood
Blood (2013) 122 (21): 575.
https://doi.org/10.1182/blood.V122.21.575.575
Published: 2013
Journal Articles

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Jan Astermark, Sharyne M. Donfield, Edward D. Gomperts, John Schwarz, Erika D. Menius, Anna Pavlova, Johannes Oldenburg, Bailey Kessing, Donna M. DiMichele, Amy D. Shapiro, Cheryl A. Winkler, Erik Berntorp
Journal: Blood
Blood (2013) 121 (8): 1446–1454.
https://doi.org/10.1182/blood-2012-06-434803
Published: 2013
Includes: Supplemental data
Journal Articles

Genetic Factors Associated with Inhibitor Development in Hemophilia A: Initial Results From the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Jan Astermark, MD, PhD, John Schwarz, MA, Sharyne M. Donfield, PhD, Donna M. DiMichele, MD, Bruce M. Ewenstein, MD, PhD, Edward D. Gomperts, MD, George W. Nelson, PhD, Johannes Oldenburg, MD, PhD, Amy D. Shapiro, MD, Gerald Spotts, PhD, Cheryl A. Winkler, PhD, Erik Berntorp, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 217.
https://doi.org/10.1182/blood.V114.22.217.217
Published: 2009
Journal Articles

Delays in maturation among adolescents with hemophilia and a history of inhibitors

Sharyne M. Donfield, Henry S. Lynn, Alice E. Lail, W. Keith Hoots, Erik Berntorp, Edward D. Gomperts
Journal: Blood
Blood (2007) 110 (10): 3656–3661.
https://doi.org/10.1182/blood-2007-05-088062
Published: 2007
Includes: Supplemental data
Journal Articles

Health-Economic Analysis of Alternative Bypassing Agents in Haemophilia Complicated by an Inhibitor - the FEIBA® NovoSeven® Comparative Study (FENOC).

Katarina Steen Carlsson, PhD, Jan Astermark, PhD, MD, Sharyne M. Donfield, PhD, Erik Berntorp, MD
Journal: Blood
Blood (2006) 108 (11): 457.
https://doi.org/10.1182/blood.V108.11.457.457
Published: 2006
Journal Articles

Association between a History of Inhibitors and Delays in Skeletal Maturation in Adolescents with Hemophilia.

Sharyne M. Donfield, PhD, Alice Lail, M.P.H., Edward D. Gomperts, M.D., W. Keith Hoots, M.D., Erik Berntorp, M.D., Ph.D., Henry S. Lynn, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1022.
https://doi.org/10.1182/blood.V108.11.1022.1022
Published: 2006
Journal Articles

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

Clinical Trials & Observations
Jan Astermark, Sharyne M. Donfield, Donna M. DiMichele, Alessandro Gringeri, Steven A. Gilbert, Jennifer Waters, Erik Berntorp, for the FENOC Study Group
Journal: Blood
Blood (2006) 109 (2): 546–551.
https://doi.org/10.1182/blood-2006-04-017988
Published: 2006